Advertisement

Topics

AXIOM VENTURE PARTNERS,L.P Company Profile

12:07 EST 14th December 2018 | BioPortfolio

Axiom Venture Partners provides capital and strategic assistance to rapidly growing high technology companies.
Axiom’s professionals bring substantial investing experience and industry expertise to the venture capital process. With over $200M in capital under management, the firm seeks to consider investment proposals in two main industry areas.

The first is High Technology which includes Communications, Software, Internet Infrastructure and Information Technology. Biotechnology constitutes the second area.

Located in Hartford, Connecticut, Axiom invests actively throughout the United States in early or late stage companies. Approximately 15 Axiom portfolio companies have successfully completed IPO’s in recent years and a number of others are positioned for IPO’s when appropriate market conditions prevail.

Given this success, Axiom’s investment returns rank near the top of its industry. Axiom is actively investing its third Partnership, Axiom Venture Partners III.

Location

S
Hartford
Connecticut
6103
United States of America

Contact

Phone: (860) 548-7799
Fax: (860) 548-7797
Email: info@silverstorm.com


News Articles [383 Associated News Articles listed on BioPortfolio]

Series B brings in $40mm for OncoResponse

OncoResponse Inc. (cancer immunotherapies) raised $40mm through its Series B round, which was led by RiverVest Venture Partners and included investments by first-time buyers Qatar Investment Authority...

GBS Venture Partners: Joshua Funder on seeing positive signs in the Australian biotech sector.

In this episode of PharmaTelevision News Review, Fintan Walton talks to Joshua Funder, Partner at GBS Venture Partners

Kymera closes $65mm Series B round

Kymera Therapeutics Inc. (protein degradation-based drug discovery) raised $65mm through its Series B round. Bessemer Venture Partners, 6 Dimensions Capital, and Pfizer Venture Investments co-led and ...

Axiom Real-Time Metrics Exhibiting at OCT Pacific Northwest in Vancouver

TORONTO, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at the Outsourcing in Clinical Trials event in Vanco...

Axiom Real-Time Metrics Exhibiting at DIA Global Annual Meeting in Boston

TORONTO, June 22, 2018 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is exhibiting at the DIA Global Annual Meeting from June 24-28, 201...

Axiom Real-Time Metrics Set to Attend the 2018 MedTech Conference in Philadelphia

TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics, premier provider of unified eClinical solutions and services, is attending the MedTech Conference in Philadelphia, Pennsylvani...

Axiom Medical Launches a New and Innovative Website

New Design and Features Enhance User Experience Axiom Medical, a leading incident case management and occupational health services provider in North America, announced the lau...

Geoff Brooke, Co-founder & Managing Partner at GBS Venture Partners

In this episode of PharmaTelevision News Review, filmed at AusBio 2012 in Melbourne, Australia, Fintan Walton talks to Geoff Brooke, Co-founder & Managing Partner at GBS Venture Partners

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [267 Associated PubMed Articles listed on BioPortfolio]

Development and Application of High-Density Axiom SNP Array with 56K SNPs to Understand the Genome Architecture of Released Cultivars and Founder Genotypes.

As one of the major outputs of next-generation sequencing (NGS), a large number of genome-wide single-nucleotide polymorphisms (SNPs) have been developed in pigeonpea [ (L.) Huth.]. However, SNPs requ...

Impact of HIV Self-Test Distribution to Male Partners of ANC Clients: Results of a Randomized Controlled Trial in Kenya.

In Kenya, HIV testing during first ANC visit is standard practice for pregnant women. Despite a policy promoting male partner testing in ANC, few male partners accompany their partners for HIV testing...

Trust, Money, and Power: Life Cycle Dynamics in Alliances Between Management Partners and Accountable Care Organizations.

Policy Points Accountable care organizations (ACOs) form alliances with management partners to access financial, technical, and managerial support. Alliances between ACOs and management partners are s...

Prevalence of HIV infection, access to HIV care, and response to antiretroviral therapy among partners of HIV-infected individuals in Thailand.

Health care providers usually focus on index HIV-infected patients and seldom obtain information from their partners. We aimed to determine HIV-preventative measures among couples, the prevalence of H...

A Misguided Venture: Presidential Fitness and the Duty to Warn.

Clinical Trials [344 Associated Clinical Trials listed on BioPortfolio]

Clinical Efficacy and Safety of Axiom Worldwide DRX9000 Axial Decompression System for Treatment of Low Back Pain

This study will document efficacy and safety of the Axiom Worldwide DRX9000™ for treatment of low back pain (LBP) in a prospective, randomized, crossover, multicenter trial utilizing a ...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Companies [1654 Associated Companies listed on BioPortfolio]

AXIOM VENTURE PARTNERS,L.P

Axiom Venture Partners provides capital and strategic assistance to rapidly growing high technology companies.Axiom’s professionals bring substantial investing experience and industry expertise to t...

Axiom Resources

Axiom Resources provides staffing solutions to the Biotechnology and Pharmaceutical industries. Our specialties include Genomics, Bioinformatics, Proteomics and Microarrays. Our extensive experience i...

Axiom Medical

Founded in 1999 and headquartered in The Woodlands, TX, Axiom is a market leader in the occupational health sector in North America, with unrivaled service quality and a very stro...

Axiom Biotechnologies Incorporated

Axiom Biotechnologies are an emerging biopharmaceutical company focused on the rapid discovery and development of more effective and safer drugs through the use of our proprietary human cell-based Phy...

Stromedix, Inc.

Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrotic organ failure. Investors in Stromedix include A...

More Information about "AXIOM VENTURE PARTNERS,L.P" on BioPortfolio

We have published hundreds of AXIOM VENTURE PARTNERS,L.P news stories on BioPortfolio along with dozens of AXIOM VENTURE PARTNERS,L.P Clinical Trials and PubMed Articles about AXIOM VENTURE PARTNERS,L.P for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AXIOM VENTURE PARTNERS,L.P Companies in our database. You can also find out about relevant AXIOM VENTURE PARTNERS,L.P Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record